Xeris Biopharma Enters Research Evaluation Collaboration and Option Agreement with Regeneron 4 hours ago
Viking Therapeutics Opening Phase 1 Study to Evaluate Oral Formulation of Dual GLP-1/GIP Receptor Agonist VK2735 2 days ago
Allarity Therapeutics Doses First Patient in Dovitinib and Stenoparib Combination Phase 1b Clinical Trial 1 week ago
Lucy Scientific Teaming Up with Pramantha Group to Target Government Contracts and Grants 2 weeks ago